Published by Josh White on 12th April 2021
(Sharecast News) - C4X Discovery has signed an exclusive worldwide licensing agreement with Sanofi worth up to €414m (£357.84m), it announced on Monday, for its oral preclinical IL-17A inhibitor programme.
URL: http://www.digitallook.com/dl/news/story/31767535/...